STAR Pharmaceutical Limited reported audited consolidated earnings results for the year ended December 31, 2017. For the year, the company reported other operating income of RMB 2,987,000, loss for the year was RMB 20,845,000, loss before tax was RMB 23,256,000 and net cash from operating activities was RMB 26,029,000.